Location: Home
  • search
  • go
  • Relate News
  • 8/16/2024Huadong Secures Asia Rights to Two South Korean Autoimmune Disease Dru...
  • 8/16/2024DualityBio Initiates Phase 1 Trial of ADC drug DB-1419 for Various Sol...
  • 8/16/2024Recent Official and Executive Moves
  • 8/15/2024Akeso's sNDA for Ivonescimab (PD-1/VEGF) Granted Priority Review in Ch...
  • 8/15/2024SAMR Releases Draft Pharma Anti-monopoly Guidelines
  • 8/15/2024China Introduces Guidelines to Encourage Development of 'Digital, Smar...
  • 8/15/2024Patent Term Compensation: New Policy Interpretation And Operation Guid...
  • 8/14/2024China Biopharma Tracker – July 2024 (PharmaDJ)
  • 8/14/2024Apollomics Announces Positive Preliminary Data of Vebreltinib
  • 8/14/2024GSK Launches Phase 3 Trial for RSV Vaccine in China
  • 8/13/2024OcuMension Acquires China Rights to Alcon Eye Drops with 16.7% Equity ...
  • 8/13/2024MNC Pharma Companies in China Return to Growth after Years of VBP Turb...
  • 8/13/2024Junshi's sNDA for Toripalimab as First-Line Treatment of Unresectable/...
  • 8/13/2024AstraZeneca and Daiichi Sankyo Secure Third Approval For Enhertu in Ch...
  • 8/12/2024Genor License ex-China Rights for CD20/CD3 Bispecific to TRC 2004
  • 8/9/2024Sable Thera Announces Worldwide Licensing Deal with Columbia Univers...
  • 8/9/2024Merck to Acquire Investigational B-Cell Depletion Therapy from Curon
  • 8/9/2024Cullinan Returns Bispecific to Harbour BioMed One Year After Paying $2...
  • 8/9/2024WuXi, Medigene Team Up for T Cell-activating Cancer Therapies
  • 8/9/2024SEED Thera Partners with Eisai in Strategic Collaboration for Novel Mo...
  • 8/9/2024LTZ Thera Announces Over $20M Series A Financing for Its Myeloid Engag...
  • 8/9/2024Recent Executive Moves
  • 8/8/2024CDE Solicits Public Comments on the Technical Guidelines for Clinical ...
  • 8/8/2024Astellas Pharma Targets China for R&D Growth and Global Impact
  • 8/8/2024Roche Launches Novel Pediatric Flu Drug in China
  • 8/8/2024WestGene Secures Dual IND Approvals for mRNA Cancer Vaccine Targeting ...
  • 8/8/2024Pharma services boom in China as CPHI & PMEC China posts record attend...
  • 8/7/2024Santen and Cloudbreak Execute A New Licensing Agreement
  • 8/7/2024NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
  • 8/7/2024A Share-listed Biopharma Cos Saw Positive Trends in H1/2024 with Incre...
  • Page:53/774 Total number of articles:23207: [First][<<] [51] [52] [53] [54] [55] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group